June 14, 2017 Jonathan Gillis Delivered via email Dear Jon:OvaScience, Inc. • August 3rd, 2017 • Pharmaceutical preparations
On behalf of OvaScience, Inc. (the “Company”), I am pleased to offer you employment with the Company. The purpose of this letter is to summarize the terms of your employment with the Company, should you accept our offer. Should you accept our offer, the terms set forth in this letter will replace and fully supersede Section 3 (“Separation Process”) of the letter dated April 28, 2017 terminating your international assignment (the “April 28, 2017 Agreement”), which you signed on May 5, 2017.
Re: Separation and General Release AgreementPersonal and Confidential • August 3rd, 2017 • OvaScience, Inc. • Pharmaceutical preparations • Massachusetts
The purpose of this letter agreement (the “Agreement”) is to set forth the terms regarding your separation of employment from OvaScience, Inc. (the “Company”) in connection with a restructuring of the Company’s operations (the “Reorganization”). As more fully set forth below, the Company desires to provide you with separation benefits in exchange for certain agreements by you. This Agreement shall become effective on the eighth (8th) day following your acceptance of it (the “Effective Date”) as described below.
Waltham, Massachusetts 02451 RE: Advisory Agreement Dear Michelle:Highly Confidential • August 3rd, 2017 • OvaScience, Inc. • Pharmaceutical preparations
You and OvaScience, Inc. (the “Company”) are parties to that certain agreement governing your employment with the Company dated January 5, 2016 (the “Original Agreement”). We have agreed on a transition plan pursuant to which you will continue for a limited period of time as the Company’s Executive Chair and then transition into a non-employee, advisory role. This letter (this “Agreement”) shall be treated as an amendment to the Original Agreement. This Agreement is effective as of June 21, 2017 (the “Effective Date”).
